Special Issue "Advances in Thrombotic Disorders and Antithrombotic Treatments"

Dear Colleagues,

Venous thromboembolism (VTE) is a chronic disease that affects nearly 10 million people every year worldwide. Cardiovascular disorders (CVDs) remain the most common cause of death in Europe. Both VTE and CVD are associated with potentially preventable morbidity and mortality. In recent decades, many efforts have been made in order to improve the diagnostic and therapeutic strategies for VTE and with the aim of reducing the burden of CVD. All novel direct oral anticoagulants introduced in the last few years have shown a favourable benefit–risk balance in terms of efficacy and safety profile, both in the prevention of thromboembolic events in atrial fibrillation and in the prevention and treatment of VTE. 

Ongoing research is, nowadays, focused on intensifying the use of oral anticoagulants in different clinical indications and, at the same time, on developing safer anticoagulant drugs, as well as improving diagnostic strategies and further personalizing approaches for the prevention and management of thrombotic disorders.

The aim of this Special Issue is to highlight recent advances related to the prevention, diagnosis, treatment and prognosis of several thrombotic conditions.

Dr. Daniela Mastroiacovo
Dr. Francesco Dentali
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• venous thromboembolism
• direct oral anticoagulants
• cardiovascular diseases
• antithrombotic treatments